Pharmaceutical oral dosage form containing a synthetic oligosaccharide

Details for Australian Patent Application No. 2010332797 (hide)

Owner Catalent France Beinheim SA Endotis Pharma

Inventors Meissonnier, Julien; Sicre, Nathalie; Sabate, Guillaume; Dubreucq, Guy; Nancy-Portebois, Vanessa; Petitou, Maurice

Agent Davies Collison Cave

Pub. Number AU-A-2010332797

PCT Pub. Number WO2011/073408

Priority 09306271.9 18.12.09 EP

Filing date 17 December 2010

Wipo publication date 23 June 2011

International Classifications

A61K 9/107 Medicinal preparations characterised by special physical form - Emulsions

A61K 9/48 Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

A61K 47/02 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

Event Publications

5 July 2012 PCT application entered the National Phase

  PCT publication WO2011/073408 Priority application(s): WO2011/073408

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010332798-Process for the preparation of thyroid hormones and salts thereof

2010332796-Maternal simulator